Antivascular Endothelial Growth Factor Antibody for Treatment of Glioblastoma Multiforme

Despite aggressive investigation, glioblastoma multiforme (GBM) remains one of the deadliest cancers, with low progression-free survival and high one-year mortality. Current first-line therapy includes surgery with adjuvant radiation therapy and cytotoxic chemotherapy, but virtually all tumors recur...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hanson, Joseph A, Hsu, Frank P K, Jacob, Arun T, Bota, Daniela A, Alexandru, Daniela
Formato: Artigo
Idioma:Inglês
Publicado: The Permanente Journal 2013
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854812/
https://ncbi.nlm.nih.gov/pubmed/24361023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/13-081
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares